Biden’s FY 2025 Budget Prioritizes Healthcare, Family Wellbeing, and Scientific Research
In March 2023, the Biden-Harris Administration released it’s FY2025 budget proposals to broaden healthcare coverage…
Browsing: Education
Aimed Alliance Comments on Oregon’s PDAB Process
On February 25, 2024, Aimed Alliance sent a letter to the Oregon Prescription Drug Affordability…
Aimed Alliance Submits Letter of Support for Biomarker Legislation
Aimed Alliance recently submitted letters of support to the Washington and Iowa legislatures urging them…
Florida Bill to Regulate Hemp-Derived Products Advances
The Florida Senate recently voted to restrict the sale of intoxicating cannabinoid products. SB 1698…
UPCOMING WEBINAR: Prescription Drug Affordability Boards 101
Join Aimed Alliance for a FREE webinar on March 18, 2024 at 11AM ET – 12:00PM…
New Resources for Consumers & Employers: DC Decision Bans Copay Accumulators
On September 29, 2023, the United States District Court for the District of Columbia held…
FDA Guidance Emphasizes Patient Engagement in Rare Disease Drug Development
The FDA recently released updated guidance, titled “Rare Diseases: Considerations for the Development of Drugs…
NEW White Paper on Alternative Funding Programs
In recent years, the adoption of alternative funding programs (AFPs) among self-funded employer-sponsored plans has…
Study Finds 340B Hospitals Significantly Markup Infusion Drugs
A recent study published in the New England Journal of Medicine examined the pricing practices…
Senators Seek Input on Draft 340B Reform Bill
The Senate 340B Working Group is soliciting additional stakeholder input on key longstanding issues surrounding…